The involvement of PKA in neurotransmitter release suggests that mutant GBA-N370S may affect DA striatal content, and that the pathophysiology of GBA-N370S variant-mediated PD may result from a disruption of the tight modulation of PKA activity. Here, GBA1 is linked to Parkinson disease.